Effectiveness of a Digitally Enabled Patient Support Program through Patient Empowerment for Comprehensive Diabetes Management
DOI:
https://doi.org/10.3329/ewmcj.v14i1.83032Keywords:
Diabetes, Digital Health, Patient Support Program, Glycemic Control, Insulin Titration, BangladeshAbstract
Background: The prevalence of diabetes in Bangladesh is rising at an alarming rate, with projections estimating an increase from 8.4 million in 2019 to 15 million by 2045. Despite medical advances, a large proportion of patients fail to achieve adequate glycemic control, due to poor adherence to lifestyle modifications and insufficient education. To address these gaps, a digitally enabled Patient Support Program (PSP) was introduced to empower patients through structured education and hybrid counseling.
Methods: A longitudinal observational study was conducted over one year with 50 insulin-treated diabetic patients. The PSP included six structured counseling sessions three telephonic consultations by physicians and three home visits by pharmacists focusing on lifestyle, diet, insulin titration, and self-monitoring of blood glucose (SMBG). Key metrics were assessed at baseline and at one year.
Results: At baseline, 23% of patients achieved fasting blood sugar (FBS) control (<8 mmol/L); this increased to 73% at one year. Weekly SMBG adherence rose from 41% to 78%. Confidence in insulin titration improved significantly, with only 11% lacking confidence post-intervention compared to 61% at baseline. Overall, 87% of participants reported high satisfaction.
Conclusion: The digitally enabled PSP significantly improved glycemic control, patient confidence, and adherence behaviors. This hybrid model holds promise for enhancing chronic disease management in resource-limited settings.
EWMCJ Vol. 14, No. 1, January 2026: 17-20
18
13
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Md. Faysal Bin Salah, Sheikh Anisul Haque, Fahmida Hoque, Khaled Hasan, Nagib Mahbub, Mohammed Mejbahuddin Mia

This work is licensed under a Creative Commons Attribution 4.0 International License.